Financials Warby Parker Inc.

Equities

WRBY

US93403J1060

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 16:00:02 2024-06-12 EDT 5-day change 1st Jan Change
16.56 USD -0.54% Intraday chart for Warby Parker Inc. -4.11% +17.45%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 5,270 1,560 1,659 1,968 - -
Enterprise Value (EV) 1 5,013 1,351 1,442 1,720 1,679 1,583
P/E ratio -21.1 x -14.1 x -26.1 x -131 x 203 x 94.6 x
Yield - - - - - -
Capitalization / Revenue 9.74 x 2.61 x 2.48 x 2.59 x 2.29 x 2.02 x
EV / Revenue 9.27 x 2.26 x 2.15 x 2.26 x 1.96 x 1.63 x
EV / EBITDA 202 x 49.7 x 27.5 x 24.4 x 18.7 x 13.2 x
EV / FCF -62.3 x -27.1 x 197 x 44.7 x 45.9 x -
FCF Yield -1.61% -3.69% 0.51% 2.24% 2.18% -
Price to Book 11.6 x 5.43 x 5.52 x 5.83 x 5.28 x 4.26 x
Nbr of stocks (in thousands) 113,183 115,624 117,640 118,862 - -
Reference price 2 46.56 13.49 14.10 16.56 16.56 16.56
Announcement Date 3/17/22 2/28/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 393.7 540.8 598.1 669.8 760.1 858.1 972.8
EBITDA 1 - 24.86 27.2 52.35 70.41 89.78 119.9
EBIT 1 - -33.12 -6.556 13.8 25.3 40.27 63.97
Operating Margin - -6.12% -1.1% 2.06% 3.33% 4.69% 6.58%
Earnings before Tax (EBT) 1 - -144 -109.9 -62.76 -7.114 24.07 32.22
Net income 1 - -144.3 -110.4 -63.2 -11.76 13.23 23.32
Net margin - -26.68% -18.46% -9.44% -1.55% 1.54% 2.4%
EPS 2 -1.050 -2.210 -0.9600 -0.5400 -0.1267 0.0817 0.1750
Free Cash Flow 1 - -80.51 -49.81 7.32 38.45 36.55 -
FCF margin - -14.89% -8.33% 1.09% 5.06% 4.26% -
FCF Conversion (EBITDA) - - - 13.98% 54.61% 40.71% -
FCF Conversion (Net income) - - - - - 276.36% -
Dividend per Share 2 - - - - - - -
Announcement Date 6/21/21 3/17/22 2/28/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 132.9 153.2 149.6 148.8 146.5 172 166.1 169.8 161.9 200 187 190.7 182 222.2 214.2
EBITDA 1 -6.399 0.774 5.936 11.93 8.568 17.74 14.18 11.03 9.408 22.38 17.24 18.61 12.42 26.6 22.36
EBIT 1 -12.95 -6.363 -1.944 2.487 -0.64 7.436 4.891 1.271 -0.962 10.32 6.616 7.784 0.6318 14.47 10.78
Operating Margin -9.74% -4.15% -1.3% 1.67% -0.44% 4.32% 2.94% 0.75% -0.59% 5.16% 3.54% 4.08% 0.35% 6.51% 5.03%
Earnings before Tax (EBT) 1 -45.79 -33.59 -32.12 -23.86 -20.33 -10.55 -15.95 -17.11 -19.15 -2.571 0.1 3 -3.7 15 10
Net income 1 -45.9 -34.13 -32.17 -23.84 -20.25 -10.81 -15.92 -17.41 -19.05 -2.679 -4.734 0.734 -4.408 15 10
Net margin -34.54% -22.28% -21.5% -16.03% -13.82% -6.29% -9.59% -10.25% -11.77% -1.34% -2.53% 0.38% -2.42% 6.75% 4.67%
EPS 2 -0.4100 -0.3000 -0.2800 -0.2100 -0.1800 -0.0900 -0.1400 -0.1500 -0.1600 -0.0200 -0.0533 -0.003330 -0.0500 0.0400 0.0100
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 3/17/22 5/16/22 8/11/22 11/10/22 2/28/23 5/9/23 8/9/23 11/8/23 2/28/24 5/9/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - -
Net Cash position 1 - 256 209 217 248 289 386
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - -80.5 -49.8 7.32 38.5 36.6 -
ROE (net income / shareholders' equity) - -328% -1.29% 4.01% 7.43% 9.11% 12.9%
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share 2 - 4.010 2.490 2.550 2.840 3.140 3.880
Cash Flow per Share 2 - - 0.0900 0.5200 -0.5100 -0.5500 -
Capex 1 - 48.5 60.2 54.7 52.8 56 64.5
Capex / Sales - 8.97% 10.06% 8.16% 6.94% 6.52% 6.63%
Announcement Date 6/21/21 3/17/22 2/28/23 2/28/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
16.56 USD
Average target price
16.5 USD
Spread / Average Target
-0.36%
Consensus
  1. Stock Market
  2. Equities
  3. WRBY Stock
  4. Financials Warby Parker Inc.